Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

Share Price is delayed by 15 minutes
Get Live Data
83.00    0.40 (0.48%)
Bid:
82.00
Ask:
84.00
Spread: 2.00 (2.439%)
Market Cap: £87.21m
SDI Live PriceLast checked at - London Stock Exchange

Intraday SDI Group Share Chart

PrimaryBid Offer

12 Feb 2019 16:31

RNS Number : 8133P
Scientific Digital Imaging Plc
12 February 2019
Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

Β 

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF SCIENTIFIC DIGITAL IMAGING PLC.

Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

Β 

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRNΒ 779021)

Β 

12 February 2019

Β 

Scientific Digital Imaging plc

Β 

("SDI" the "Company", or the "Group")

Β 

(AIM: SDI)

Β 

Β 

PrimaryBid Offer

Β 

Β 

At 4:30 p.m. on 12 February 2019 the Company issued an announcement through RNS (the "Announcement") of a placing (the "Placing") at an issue price of 34 pence per New Ordinary Share (the "Issue Price"). In addition, the Company is pleased to announce an offer for subscription for up to 294,117 New Ordinary Shares at the Issue Price through PrimaryBid Limited (the "Offer").Β The Offer, if subscribed for in full, would fully utilise the Company's remaining existing authorities to issue and allot for cash New Ordinary Shares in the Company. The funds raised by way of the Offer will be used to strengthen the balance sheet of the Company by reducing its net debt position following the acquisition of Graticules.

Β 

The opportunity to participate in the Offer is at an issue price of 34 (the "Issue Price") pence per New Ordinary Share.

Β 

Offer

Β 

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the Offer by applying exclusively through the www.PrimaryBid.com platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

Β 

The Offer, via the PrimaryBid.com platform, will be open to individual and institutional investors from 4.31 p.m. onΒ 12 February 2019 to 9.00 p.m. on 12 February 2019. The Offer may close early if it is oversubscribed.

Β 

Subscriptions under the Offer will be considered by the Company on a "first come, first served" basis, subject to conditions (which are available to view on PrimaryBid.com) with any investment request over Β£25,000 first requiring consultation with the Company.

Β 

No commission is charged to investors on applications to participate in the Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

Β 

For further information on PrimaryBid.com or the procedure for applications under the Offer, visitΒ www.PrimaryBid.comΒ or call PrimaryBid.com on +44 20 3026 4750.Β 

Β 

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rankΒ pari passuΒ in all respects with the Company's existing Ordinary Shares.

Β 

Enquiries

Β 

Scientific Digital Imaging plc +44 1223 320480

Ken Ford, Chairman

Mike Creedon, CEO

Jon Abell, CFO

www.scientificdigitalimaging.com

Β 

finnCap Ltd +44 20 7220 0500

Ed Frisby/Kate Bannatyne - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

Β 

PrimaryBid Limited +44 20 3026 4750

Robert Beenstock

Β 

JW Communications +44 7818 430877

Julia Wilson - Investor & Public Relations

Β 

Β 

Details of the Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the Offer. The Company is therefore making the Offer available exclusively through PrimaryBid.com.

Β 

Retail and other investors may participate in the Offer of New Ordinary Shares on a first come, first served basis, exclusively through PrimaryBid.com.

Β 

The Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of aΒ prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so. finnCap is not acting for the Company in relation to the PrimaryBid Offer

Β 

There is a minimum subscription of Β£100 per investor under the terms of the Offer which is open to existing shareholders and other investors subscribing via PrimaryBid.com. This allocation will be filled on a "first come first served" basis.

Β 

Any investment request in excess of Β£25,000 will require the Company's consent and may be subject to scale back.

Β 

For further details please refer to the PrimaryBid.com website atΒ www.PrimaryBid.com. The terms and conditions on which the Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

Β 

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

Β 

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt.Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
FURBLGDDLDBBGCD
Date   Source Headline
21st Jul 20227:00 amRNSFinal Results
19th Jul 20222:20 pmRNSNotice of Results and Investor Presentation
30th Jun 20227:00 amRNSBoard Changes
6th May 20229:08 amRNSSecond Price Monitoring Extn
6th May 20227:00 amRNSTrading Update
26th Apr 20225:20 pmRNSChange of Website
28th Mar 20227:00 amRNSAcquisition of Safelab Systems Limited and TVR
18th Mar 20221:10 pmRNSExercise of Share Options and Total Voting Rights
14th Jan 20222:40 pmRNSResult of Secondary Placing
14th Jan 20221:30 pmRNSSecondary Placing, Exercise of Options & TVR
11th Jan 20227:00 amRNSBoard Change
7th Jan 20227:00 amRNSAcquisition of SVS and Atik Order
17th Dec 202112:10 pmRNSExercise of Share Options and Total Voting Rights
7th Dec 20217:00 amRNSInterim Results
12th Nov 20217:00 amRNSInvestor Presentation
4th Nov 20217:00 amRNSTrading Update and Notice of Results
15th Oct 202112:45 pmRNSHolding(s) in Company
1st Oct 20215:15 pmRNSTotal Voting Rights
1st Oct 202112:45 pmRNSLong Term Incentive Plan Awards
23rd Sep 202111:15 amRNSHolding(s) in Company
22nd Sep 20214:28 pmRNSResult of AGM
22nd Sep 20217:00 amRNSAGM Trading Update
3rd Sep 202111:30 amRNSExercise of Options, Director Shareholding and TVR
26th Aug 20219:45 amRNSHolding(s) in Company
23rd Aug 202111:45 amRNSPosting of Annual Report and Notice of AGM
20th Jul 20217:00 amRNSFinal Results
1st Jul 20214:30 pmRNSTotal Voting Rights
23rd Jun 20217:00 amRNSInvestor Presentation
10th Jun 202112:45 pmRNSHolding(s) in Company
27th May 20215:30 pmRNSExercise of Options, Director Shareholding & TVR
26th May 20216:15 pmRNSDirector Dealing
26th May 20217:00 amRNSTrading Update
12th May 20217:00 amRNSNotice of Results
26th Apr 20219:25 amRNSExercise of Options and Total Voting Rights
14th Apr 20214:26 pmRNSExercise of Options and Total Voting Rights
14th Apr 20214:16 pmRNSDirector Dealing
6th Apr 20213:50 pmRNSExercise of Options and Total Voting Rights
1st Apr 20213:13 pmRNSDirector Dealing
3rd Mar 20212:19 pmRNSHolding(s) in Company
2nd Mar 20214:53 pmRNSHolding(s) in Company
22nd Feb 20214:41 pmRNSHolding(s) in Company
10th Feb 20214:05 pmRNSHolding(s) in Company
10th Feb 20219:06 amRNSSecond Price Monitoring Extn
10th Feb 20219:03 amRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSTrading Update
1st Feb 20217:00 amRNSAcquisition of Uniform Engineering
19th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
13th Jan 20215:20 pmRNSExercise of Options and Total Voting Rights
12th Jan 20217:23 amRNSProgressive publishes new research
5th Jan 20217:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.